Xarelto, a blood thinner used to prevent clotting, can cause extreme bleeding. Untreated bleeding elevates Xarelto side effects to a potentially fatal status.
Get our reporting in your inbox
Read more about Xarelto
FDA Delays AndexXa Antidote for Xarelto ...
Ashley Lombardo · January 24, 2018
The AndexXa antidote, intended to stop Xarelto bleeding, awaits FDA approval. The agency will revisit the data in May 2018.FDA Regulation
Xarelto Gets FDA Approval to Extend VTE ...
Ashley Lombardo · November 17, 2017
The Food and Drug Administration approved the blood thinner Xarelto for extended VTE prevention. The medication has been linked to severe bleeding.FDA Regulation
Xarelto Study On Stroke Prevention Ends ...
Ashley Lombardo · October 17, 2017
A Xarelto study on stroke prevention ended early after the drug failed to demonstrate any advantage over taking aspirin.Research + Findings
Xarelto Reversal Strategies and Bleeding Management
Ashley Lombardo · October 3, 2017
Xarelto reversal strategies are very important: patients need help with bleeding management in the event of a problem.News
Antidote for Xarelto’s Extreme Bleeding May Be on the Horizon
Ashley Lombardo · February 28, 2017
Portola Pharmaceuticals is manufacturing an antidote for the extreme bleeding side effect linked to Eliquis and Xarelto.News
Did a Defective Blood Machine Alter Xarelto’s Clinical Trial?
Ashley Lombardo · September 30, 2016
A new investigation into Rocket AF, the Xarelto clinical trial, have regulators questioning the safety approval of the popular blood thinner.Research + Findings